Challenges of implementing fibromyalgia treatment guidelines in current clinical practice

References

• Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010;62(5):600–610.
   PubMed Web of Science ®Google Scholar
• Nampiaparampil DE, Shmerling RH. A review of fibromyalgia. Am J Manag Care. 2004;10(11 Pt 1):794–800.
   PubMed Web of Science ®Google Scholar
• Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013;17(8):356.
   PubMed Web of Science ®Google Scholar
• Clauw DJ, Arnold LM, McCarberg BH. The science of fibromyalgia. Mayo Clin Proc. 2011;86(9):907–911.
   PubMed Web of Science ®Google Scholar
• Arnold LM, Gebke KB, Choy EH. Fibromyalgia: management strategies for primary care providers. Int J Clin Pract. 2016;70(2):99–112.
   PubMed Web of Science ®Google Scholar
• Smith HS, Barkin RL. Fibromyalgia syndrome: a discussion of the syndrome and pharmacotherapy. Dis Mon. 2011;57(5):248–285.
   PubMed Web of Science ®Google Scholar
• Choy E, Perrot S, Leon T, et al. A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC Health Serv Res. 2010;10:102.
   PubMed Web of Science ®Google Scholar
• Robinson RL, Birnbaum HG, Morley MA, et al. Economic cost and epidemiological characteristics of patients with fibromyalgia claims. J Rheumatol. 2003;30(6):1318–1325.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Michaud K, Li T, et al. Chronic conditions and health problems in rheumatic diseases: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia. J Rheumatol. 2010;37(2):305–315.
   PubMed Web of Science ®Google Scholar
• Weir PT, Harlan GA, Nkoy FL, et al. The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th Revision codes. J Clin Rheumatol. 2006;12(3):124–128.
   PubMed Web of Science ®Google Scholar
• Fitzcharles MA, Ste-Marie PA, Goldenberg DL, et al. 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. Pain Res Manag. 2013;18(3):119–126.
   PubMed Web of Science ®Google Scholar
• Macfarlane GJ, Kronisch C, Dean LE, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017;76(2):318–328.
   PubMed Web of Science ®Google Scholar
• Arnold LM. Biology and therapy of fibromyalgia. New therapies in fibromyalgia. Arthritis Res Ther. 2006;8(4):212.
   PubMed Web of Science ®Google Scholar
• Busch AJ, Webber SC, Brachaniec M, et al. Exercise therapy for fibromyalgia. Curr Pain Headache Rep. 2011;15(5):358–367.
   PubMed Web of Science ®Google Scholar
• Dailey DL, Keffala VJ, Sluka KA. Do cognitive and physical fatigue tasks enhance pain, cognitive fatigue, and physical fatigue in people with fibromyalgia? Arthritis Care Res (Hoboken). 2015;67(2):288–296.
   PubMed Web of Science ®Google Scholar
• Hassett AL, Gevirtz RN. Nonpharmacologic treatment for fibromyalgia: patient education, cognitive-behavioral therapy, relaxation techniques, and complementary and alternative medicine. Rheum Dis Clin North Am. 2009;35(2):393–407.
   PubMed Web of Science ®Google Scholar
• Ablin J, Fitzcharles MA, Buskila D, et al. Treatment of fibromyalgia syndrome: recommendations of recent evidence-based interdisciplinary guidelines with special emphasis on complementary and alternative therapies. Evid Based Complement Alternat Med. 2013;2013:1–7.
   Web of Science ®Google Scholar
• McNett M, Goldenberg D, Schaefer C, et al. Treatment patterns among physician specialties in the management of fibromyalgia: results of a cross-sectional study in the United States. Curr Med Res Opin. 2011;27(3):673–683.
   PubMed Web of Science ®Google Scholar
• Robinson RL, Kroenke K, Mease P, et al. Burden of illness and treatment patterns for patients with fibromyalgia. Pain Med. 2012;13(10):1366–1376.
   PubMed Web of Science ®Google Scholar
• Liu Y, Qian C, Yang M. Treatment patterns associated with ACR-recommended medications in the management of fibromyalgia in the United States. J Manag Care Spec Pharm. 2016;22(3):263–271.
   PubMedGoogle Scholar
• Gilron I, Jensen TS, Dickenson AH. Combination pharmacotherapy for management of chronic pain: from bench to bedside. Lancet Neurol. 2013;12(11):1084–1095.
   PubMed Web of Science ®Google Scholar
• Mease PJ, Dundon K, Sarzi-Puttini P. Pharmacotherapy of fibromyalgia. Best Pract Res Clin Rheumatol. 2011;25(2):285–297.
   PubMed Web of Science ®Google Scholar
• White LA, Birnbaum HG, Kaltenboeck A, et al. Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss. J Occup Environ Med. 2008;50(1):13–24.
   PubMed Web of Science ®Google Scholar
• Robinson RL, Kroenke K, Williams DA, et al. Longitudinal observation of treatment patterns and outcomes for patients with fibromyalgia: 12-month findings from the reflections study. Pain Med. 2013;14(9):1400–1415.
   PubMed Web of Science ®Google Scholar
• Bennett RM, Jones J, Turk DC, et al. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord. 2007;8(1):27.
   PubMed Web of Science ®Google Scholar
• Goldenberg DL, Clauw DJ, Palmer RE, et al. Opioid use in fibromyalgia: a cautionary tale. Mayo Clin Proc. 2016;91(5):640–648.
   PubMed Web of Science ®Google Scholar
• Williams DA, Kuper D, Segar M, et al. Internet-enhanced management of fibromyalgia: a randomized controlled trial. Pain. 2010;151(3):694–702.
   PubMed Web of Science ®Google Scholar
• Busch AJ, Barber KA, Overend TJ, et al. Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev. 2007;4:CD003786.
   PubMed Web of Science ®Google Scholar
• Edinger JD, Wohlgemuth WK, Krystal AD, et al. Behavioral insomnia therapy for fibromyalgia patients: a randomized clinical trial. Arch Intern Med. 2005;165(21):2527–2535.
   PubMedGoogle Scholar
• King SJ, Wessel J, Bhambhani Y, et al. The effects of exercise and education, individually or combined, in women with fibromyalgia. J Rheumatol. 2002;29(12):2620–2627.
   PubMed Web of Science ®Google Scholar
• Carson JW, Carson KM, Jones KD, et al. A pilot randomized controlled trial of the Yoga of Awareness program in the management of fibromyalgia. Pain. 2010;151(2):530–539.
   PubMed Web of Science ®Google Scholar
• Vas J, Santos-Rey K, Navarro-Pablo R, et al. Acupuncture for fibromyalgia in primary care: a randomised controlled trial. Acupunct Med. 2016;34(4):257–266.
   PubMed Web of Science ®Google Scholar
• Wang C, Schmid CH, Rones R, et al. A randomized trial of tai chi for fibromyalgia. N Engl J Med. 2010;363(8):743–754.
   PubMed Web of Science ®Google Scholar
• Van Koulil S, Van Lankveld W, Kraaimaat FW, et al. Tailored cognitive-behavioral therapy and exercise training for high-risk patients with fibromyalgia. Arthritis Care Res (Hoboken). 2010;62(10):1377–1385.
   PubMed Web of Science ®Google Scholar
• LYRICA [package insert]. LYRICA (pregabalin) caspules, CV; LYRICA (pregabalin) oral solution, CV. New York, NY: Parke-Davis Division of Pfizer, Inc.; 2016.
   Google Scholar
• CYMBALTA [package insert]. CYMBALTA (duloxetine delayed-release capsules) for oral use. Indianapolis, IN: Lilly USA, LLC; 2016.
   Google Scholar
• Savella® [package insert] (milnacipran HCl) Tablets. Irvine, CA: Allergan, Inc.; 2016.
   Google Scholar
• Crofford LJ, Rowbotham MC, Mease PJ, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2005;52(4):1264–1273.
   PubMed Web of Science ®Google Scholar
• Gendreau RM, Thorn MD, Gendreau JF, et al. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol. 2005;32(10):1975–1985.
   PubMed Web of Science ®Google Scholar
• Arnold LM, Rosen A, Pritchett YL, et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain. 2005;119(1–3):5–15.
   PubMed Web of Science ®Google Scholar
• Arnold LM, Lu Y, Crofford LJ, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum. 2004;50(9):2974–2984.
   PubMed Web of Science ®Google Scholar
• Arnold LM, Williams DA, Hudson JI, et al. Development of responder definitions for fibromyalgia clinical trials. Arthritis Rheum. 2012;64(3):885–894.
   PubMed Web of Science ®Google Scholar
• Hauser W, Petzke F, Sommer C. Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome. J Pain. 2010;11(6):505–521.
   PubMed Web of Science ®Google Scholar
• Arnold LM, Sarzi-Puttini P, Arsenault P, et al. Efficacy and safety of pregabalin in patients with fibromyalgia and comorbid depression taking concurrent antidepressant medication: a randomized, placebo-controlled study. J Rheumatol. 2015;42(7):1237–1244.
   PubMed Web of Science ®Google Scholar
• Arnold LM, Wang F, Ahl J, et al. Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial. Arthritis Res Ther. 2011;13(3):R86.
   PubMed Web of Science ®Google Scholar
• Milnacipran hydrochloride 25 mg and 50 mg capsules [package leaflet]. Essex, UK: Double-E Pharma Ltd.; 2015.
   Google Scholar
• European Medicines Agency. List of nationally authorised medicinal products. Active substance: milnacipran. [cited 2017 Apr 27]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Periodic_safety_update_single_assessment/2016/10/WC500214560.pdf.
   Google Scholar
• Gilron I, Chaparro LE, Tu D, et al. Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial. Pain. 2016;157(7):1532–1540.
   PubMed Web of Science ®Google Scholar
• Arnold LM, Cappelleri JC, Clair A, et al. Interpreting effect sizes and clinical relevance of pharmacological interventions for fibromyalgia. Pain Ther. 2013;2(1):65–71.
   PubMedGoogle Scholar
• Briley M. Drugs to treat fibromyalgia - the transatlantic difference. Curr Opin Investig Drugs. 2010;11(1):16–18.
   PubMedGoogle Scholar